US Stock MarketDetailed Quotes

VERA Vera Therapeutics

Watchlist

47.460
+0.190+0.40%

Close Nov 26 16:00 ET

47.460
0.0000.00%

Post 17:28 ET

3.01BMarket Cap-18183P/E (TTM)

Vera Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-60.56%-36.89M

-39.44%-24.78M

-28.67%-33.83M

-36.37%-92.18M

-18.82%-25.14M

-24.72%-22.97M

6.63%-17.77M

-192.75%-26.29M

-185.12%-67.6M

-228.70%-21.16M

Net income from continuing operations

-131.95%-46.63M

-67.19%-33.71M

5.61%-28.38M

-7.79%-95.99M

20.91%-25.66M

18.54%-20.1M

-35.74%-20.16M

-76.00%-30.07M

-173.10%-89.06M

-92.55%-32.44M

Depreciation and amortization

300.00%24K

189.17%1.5M

-190.32%-1.47M

-382.98%-4.09M

-587.27%-4.1M

103.95%6K

587.74%517K

-5,722.22%-506K

-580.68%-846K

-1,965.63%-597K

Other non cash items

11.94%703K

23.99%889K

-10.71%517K

-62.07%2.22M

-42.97%300K

-85.13%628K

30.13%717K

2.66%579K

46.54%5.86M

-89.21%526K

Change In working capital

219.68%5.86M

5,242.61%6.14M

-931.15%-8.62M

-186.99%-5.87M

-124.86%-2.12M

-953.55%-4.9M

101.60%115K

-82.33%1.04M

92.17%6.75M

98.88%8.54M

-Change in prepaid assets

11.69%-1.84M

218.36%2.72M

-110.46%-392K

102.11%173K

267.84%809K

-1,255.19%-2.09M

36.24%-2.3M

195.10%3.75M

-254.81%-8.18M

-168.27%-482K

-Change in payables and accrued expense

468.51%8M

20.49%4.03M

-274.70%-7.6M

-117.50%-3.09M

-122.99%-2.24M

-640.30%-2.17M

226.34%3.35M

-119.95%-2.03M

200.65%17.64M

167.36%9.72M

-Change in other current assets

2,809.09%320K

104.81%13K

325.00%9K

-178.38%-309K

-253.85%-46K

116.67%11K

10.89%-270K

-101.48%-4K

-117.65%-111K

74.51%-13K

-Change in other current liabilities

5.07%-618K

6.32%-623K

6.32%-637K

-1.65%-2.65M

6.35%-649K

-0.62%-651K

-4.56%-665K

-8.63%-680K

---2.6M

---693K

Cash from discontinued investing activities

Operating cash flow

-60.56%-36.89M

-39.44%-24.78M

-28.67%-33.83M

-36.37%-92.18M

-18.82%-25.14M

-24.72%-22.97M

6.63%-17.77M

-192.75%-26.29M

-185.12%-67.6M

-228.70%-21.16M

Investing cash flow

Cash flow from continuing investing activities

136.12%38.32M

73.77%-22.68M

-1,892.43%-219.29M

44.11%-39.43M

38.10%18.56M

765.08%16.23M

-105.37%-86.45M

131.01%12.23M

-1,578.21%-70.55M

368.74%13.44M

Net PPE purchase and sale

---238K

----

-1.61%-63K

---63K

--0

----

---62K

--0

Net investment purchase and sale

137.58%38.56M

73.87%-22.59M

-1,892.43%-219.29M

44.15%-39.37M

38.57%18.62M

775.60%16.23M

-105.40%-86.45M

131.02%12.23M

---70.49M

--13.44M

Cash from discontinued investing activities

Investing cash flow

136.12%38.32M

73.77%-22.68M

-1,892.43%-219.29M

44.11%-39.43M

38.10%18.56M

765.08%16.23M

-105.37%-86.45M

131.01%12.23M

-1,578.21%-70.55M

368.74%13.44M

Financing cash flow

Cash flow from continuing financing activities

148.82%739K

696.06%3.44M

156.09%276.54M

31.01%133.54M

19.89%24.83M

-67.29%297K

800.00%432K

34.53%107.98M

89.18%101.93M

320.83%20.71M

Net issuance payments of debt

----

24.85%24.74M

----

302.68%19.82M

----

Net common stock issuance

---13K

--0

150.03%287.54M

33.52%115M

--0

33.52%115M

68.30%86.13M

---1K

Proceeds from stock option exercised by employees

153.20%752K

696.06%3.44M

2,779.58%6.91M

-49.30%1.06M

-89.48%87K

-69.54%297K

819.15%432K

2.56%240K

278.73%2.08M

--827K

Net other financing activities

--0

-146.80%-17.91M

-19.01%-7.26M

--0

-19.03%-7.26M

-120.51%-6.1M

--67K

Cash from discontinued financing activities

Financing cash flow

148.82%739K

696.06%3.44M

156.09%276.54M

31.01%133.54M

19.89%24.83M

-67.29%297K

800.00%432K

34.53%107.98M

89.18%101.93M

320.83%20.71M

Net cash flow

Beginning cash position

-25.98%25.09M

-49.81%69.11M

4.41%45.68M

-45.29%43.75M

-10.81%27.44M

-33.18%33.89M

23.15%137.68M

-45.29%43.75M

48.10%79.97M

-64.42%30.77M

Current changes in cash

133.67%2.17M

57.59%-44.02M

-75.06%23.42M

105.33%1.93M

40.48%18.24M

67.68%-6.45M

-69.93%-103.79M

195.07%93.93M

-239.45%-36.22M

299.23%12.98M

End cash Position

-0.67%27.26M

-25.98%25.09M

-49.81%69.11M

4.41%45.68M

-10.81%27.44M

-33.18%33.89M

23.15%137.68M

-45.29%43.75M

Free cash flow

-61.59%-37.12M

-39.94%-24.87M

-28.67%-33.83M

-36.34%-92.24M

-19.11%-25.21M

-24.46%-22.97M

6.65%-17.77M

-192.17%-26.29M

-185.38%-67.66M

-228.70%-21.16M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-60.56%-36.89M	-39.44%-24.78M	-28.67%-33.83M	-36.37%-92.18M	-18.82%-25.14M	-24.72%-22.97M	6.63%-17.77M	-192.75%-26.29M	-185.12%-67.6M	-228.70%-21.16M
Net income from continuing operations	-131.95%-46.63M	-67.19%-33.71M	5.61%-28.38M	-7.79%-95.99M	20.91%-25.66M	18.54%-20.1M	-35.74%-20.16M	-76.00%-30.07M	-173.10%-89.06M	-92.55%-32.44M
Depreciation and amortization	300.00%24K	189.17%1.5M	-190.32%-1.47M	-382.98%-4.09M	-587.27%-4.1M	103.95%6K	587.74%517K	-5,722.22%-506K	-580.68%-846K	-1,965.63%-597K
Other non cash items	11.94%703K	23.99%889K	-10.71%517K	-62.07%2.22M	-42.97%300K	-85.13%628K	30.13%717K	2.66%579K	46.54%5.86M	-89.21%526K
Change In working capital	219.68%5.86M	5,242.61%6.14M	-931.15%-8.62M	-186.99%-5.87M	-124.86%-2.12M	-953.55%-4.9M	101.60%115K	-82.33%1.04M	92.17%6.75M	98.88%8.54M
-Change in prepaid assets	11.69%-1.84M	218.36%2.72M	-110.46%-392K	102.11%173K	267.84%809K	-1,255.19%-2.09M	36.24%-2.3M	195.10%3.75M	-254.81%-8.18M	-168.27%-482K
-Change in payables and accrued expense	468.51%8M	20.49%4.03M	-274.70%-7.6M	-117.50%-3.09M	-122.99%-2.24M	-640.30%-2.17M	226.34%3.35M	-119.95%-2.03M	200.65%17.64M	167.36%9.72M
-Change in other current assets	2,809.09%320K	104.81%13K	325.00%9K	-178.38%-309K	-253.85%-46K	116.67%11K	10.89%-270K	-101.48%-4K	-117.65%-111K	74.51%-13K
-Change in other current liabilities	5.07%-618K	6.32%-623K	6.32%-637K	-1.65%-2.65M	6.35%-649K	-0.62%-651K	-4.56%-665K	-8.63%-680K	---2.6M	---693K
Cash from discontinued investing activities
Operating cash flow	-60.56%-36.89M	-39.44%-24.78M	-28.67%-33.83M	-36.37%-92.18M	-18.82%-25.14M	-24.72%-22.97M	6.63%-17.77M	-192.75%-26.29M	-185.12%-67.6M	-228.70%-21.16M
Investing cash flow
Cash flow from continuing investing activities	136.12%38.32M	73.77%-22.68M	-1,892.43%-219.29M	44.11%-39.43M	38.10%18.56M	765.08%16.23M	-105.37%-86.45M	131.01%12.23M	-1,578.21%-70.55M	368.74%13.44M
Net PPE purchase and sale	---238K	----	----	-1.61%-63K	---63K	--0	----	----	---62K	--0
Net investment purchase and sale	137.58%38.56M	73.87%-22.59M	-1,892.43%-219.29M	44.15%-39.37M	38.57%18.62M	775.60%16.23M	-105.40%-86.45M	131.02%12.23M	---70.49M	--13.44M
Cash from discontinued investing activities
Investing cash flow	136.12%38.32M	73.77%-22.68M	-1,892.43%-219.29M	44.11%-39.43M	38.10%18.56M	765.08%16.23M	-105.37%-86.45M	131.01%12.23M	-1,578.21%-70.55M	368.74%13.44M
Financing cash flow
Cash flow from continuing financing activities	148.82%739K	696.06%3.44M	156.09%276.54M	31.01%133.54M	19.89%24.83M	-67.29%297K	800.00%432K	34.53%107.98M	89.18%101.93M	320.83%20.71M
Net issuance payments of debt	----	----	----	24.85%24.74M	----	----	----	----	302.68%19.82M	----
Net common stock issuance	---13K	--0	150.03%287.54M	33.52%115M	--0	--0	--0	33.52%115M	68.30%86.13M	---1K
Proceeds from stock option exercised by employees	153.20%752K	696.06%3.44M	2,779.58%6.91M	-49.30%1.06M	-89.48%87K	-69.54%297K	819.15%432K	2.56%240K	278.73%2.08M	--827K
Net other financing activities	--0	--0	-146.80%-17.91M	-19.01%-7.26M	--0	--0	--0	-19.03%-7.26M	-120.51%-6.1M	--67K
Cash from discontinued financing activities
Financing cash flow	148.82%739K	696.06%3.44M	156.09%276.54M	31.01%133.54M	19.89%24.83M	-67.29%297K	800.00%432K	34.53%107.98M	89.18%101.93M	320.83%20.71M
Net cash flow
Beginning cash position	-25.98%25.09M	-49.81%69.11M	4.41%45.68M	-45.29%43.75M	-10.81%27.44M	-33.18%33.89M	23.15%137.68M	-45.29%43.75M	48.10%79.97M	-64.42%30.77M
Current changes in cash	133.67%2.17M	57.59%-44.02M	-75.06%23.42M	105.33%1.93M	40.48%18.24M	67.68%-6.45M	-69.93%-103.79M	195.07%93.93M	-239.45%-36.22M	299.23%12.98M
End cash Position	-0.67%27.26M	-25.98%25.09M	-49.81%69.11M	4.41%45.68M	4.41%45.68M	-10.81%27.44M	-33.18%33.89M	23.15%137.68M	-45.29%43.75M	-45.29%43.75M
Free cash flow	-61.59%-37.12M	-39.94%-24.87M	-28.67%-33.83M	-36.34%-92.24M	-19.11%-25.21M	-24.46%-22.97M	6.65%-17.77M	-192.17%-26.29M	-185.38%-67.66M	-228.70%-21.16M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data